- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 37/04 - Immunostimulants
Patent holdings for IPC class A61P 37/04
Total number of patents in this class: 6136
10-year publication summary
|
132
|
188
|
259
|
244
|
330
|
411
|
412
|
576
|
558
|
82
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Glaxosmithkline Biologicals S.A. | 1620 |
64 |
| The Trustees of the University of Pennsylvania | 4387 |
61 |
| The Regents of the University of California | 20410 |
60 |
| Osaka University | 3355 |
46 |
| National Research Council of Canada | 1566 |
38 |
| The University of British Columbia | 1537 |
37 |
| Bristol-myers Squibb Company | 4795 |
36 |
| University of Saskatchewan | 481 |
36 |
| The Governors of the University of Alberta | 871 |
35 |
| Universite de Montreal | 342 |
31 |
| The University of Tokyo | 4297 |
31 |
| Toray Industries, Inc. | 7016 |
30 |
| Nestec S.A. | 2612 |
29 |
| Merck Sharp & Dohme LLC | 3741 |
28 |
| President and Fellows of Harvard College | 6054 |
27 |
| Kyoto University | 2878 |
27 |
| Memorial Sloan-Kettering Cancer Center | 1992 |
27 |
| Pfizer Inc. | 3373 |
25 |
| Inovio Pharmaceuticals, Inc. | 325 |
25 |
| Zoetis Services LLC | 1526 |
25 |
| Other owners | 5418 |